This is a study of the commercial development of biotechnology that compares the initiatives, activities and organization of two firms--Genentech in the United States and Kabi in Sweden--as they brought knowledge to the market in the form of insulin and the human growth hormone. Writing from a broad evolutionary perspective, Maureen McKelvey's important study of one of the most modern science-based technologies will be of interest to all concerned with understanding the processes of innovation.
Evolutionary Innovations: The Business of Biotechnology
and over one million other books are available for Amazon Kindle.
Learn more
FREE Two-Day Shipping for students on millions of items. Learn more |
| ||||||||||||||||||||||||
Book Description
Special Offers and Product Promotions
- Buy $50 in qualifying physical textbooks, get $5 in Amazon MP3 Credit. Here's how (restrictions apply)
Editorial Reviews
Review
"Evolutionary Innovations...is fascinating, historically significant, and dramatic."--Nature Biotechnology
"..fascinating.... The analysis of the historical developments of biotechnology is both rooted in theoretical ideas and a source of possible generalizations. We need more books of this type."--EAEPE Newsletter
"Good reading for economists and others interested in the biotechnology industry."--Choice
"...well-written and thoroughly researched....Her study makes an important contribution to the development of that theory and to the growing body of work on the history of biotechnology and innovation."--Technology and Culture
About the Author
Maureen McKelvey is Associate Professor in the Department of Technology and Social Change, Linkoping University, Sweden.
Product Details
Would you like to update product info or give feedback on images?
|
More About the Author
Discover books, learn about writers, read author blogs, and more.
Customer Reviews
|
There are no customer reviews yet.
|
|||
|
Video reviews
|
Inside This Book
(learn more)
First Sentence:
Arguments about the importance of 'market pull' versus 'technology push' are in this sense artificial, since each market need entering the innovation cycle leads in time to a new design, and every successful new design, in time, leads to new market conditions. Read the first page Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
basic scientific environment, national public contexts, somatostatin experiment, radical versus incremental change, early commercial uses, dedicated biotech firm, bacteria expression system, basic scientific results, new biotech firms, evolutionary technical change, basic scientific activities, genetic engineering knowledge, functioning production system, commercial trajectory, technological innovation processes, corporate researchers, innovating agents, more sensitive analytical methods, extra methionine, involving genetic engineering, engineered pharmaceuticals, genetic engineering techniques, genetically modified bacteria, human pituitary glands, technological activities Key Phrases - Capitalized Phrases (CAPs): (learn more)
Generating Research, Specific Firm Challenges, Eli Lilly, Evolutionary Innovations, United States, City of Hope, San Francisco, Understanding Genetic Engineering, Porton Down, Stanford University, University of California, Medical World News, Centre Party, Dagens Nyheter, Stanford Research Institute, Hans Sievertsson, Peter Seeburg, Academic Senate, Pajaro Dunes, Pasteur Institute, Axel Ullrich, Linda Fryklund, Nobel Prize, Professor Boyer, The Economist New!
Books on Related Topics | Concordance | Text Stats Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Arguments about the importance of 'market pull' versus 'technology push' are in this sense artificial, since each market need entering the innovation cycle leads in time to a new design, and every successful new design, in time, leads to new market conditions. Read the first page Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
basic scientific environment, national public contexts, somatostatin experiment, radical versus incremental change, early commercial uses, dedicated biotech firm, bacteria expression system, basic scientific results, new biotech firms, evolutionary technical change, basic scientific activities, genetic engineering knowledge, functioning production system, commercial trajectory, technological innovation processes, corporate researchers, innovating agents, more sensitive analytical methods, extra methionine, involving genetic engineering, engineered pharmaceuticals, genetic engineering techniques, genetically modified bacteria, human pituitary glands, technological activities Key Phrases - Capitalized Phrases (CAPs): (learn more)
Generating Research, Specific Firm Challenges, Eli Lilly, Evolutionary Innovations, United States, City of Hope, San Francisco, Understanding Genetic Engineering, Porton Down, Stanford University, University of California, Medical World News, Centre Party, Dagens Nyheter, Stanford Research Institute, Hans Sievertsson, Peter Seeburg, Academic Senate, Pajaro Dunes, Pasteur Institute, Axel Ullrich, Linda Fryklund, Nobel Prize, Professor Boyer, The Economist New!
Books on Related Topics | Concordance | Text Stats Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Citations (learn more)
This book cites 71
books:
See all 71 books this book cites
14
books
cite this book:
See all 14 books citing this book
- Genetic Engineering (Opposing Viewpoints) by Greenhaven Press on 5 pages
- Technical Change and Economic Theory (Ifias Research Series, Number 6) by Giovanni Dosi on 4 pages
- The Positive Sum Strategy: Harnessing Technology for Economic Growth by Ralph Landau in Back Matter (1), Back Matter (2), and Back Matter (3)
- The Evolution of Technology (Cambridge Studies in the History of Science) by George Basalla on page 30, and page 299
- Protein Purification: From Molecular Mechanisms to Large-Scale Processes (Acs Symposium Series) by Michael R. Ladisch in Back Matter (1), and Back Matter (2)
See all 71 books this book cites
- Science Business: The Promise, the Reality, and the Future of Biotech by Gary P. Pisano in Back Matter (1), and Back Matter (2)
- Shaping the Industrial Century: The Remarkable Story of the Evolution of the Modern Chemical and Pharmaceutical Industries (Harvard Studies in Business History) by Alfred D. Chandler Jr. in Back Matter (1), and Back Matter (2)
- Cluster Genesis: Technology-Based Industrial Development by Pontus Braunerhjelm in Back Matter
- The Power of the Tale: Using Narratives for Organisational Success by Julie Allan in Back Matter
- Globalization and Technology: Interdependence, Innovation Systems and Industrial Policy by Rajneesh Narula in Back Matter
See all 14 books citing this book
Books on Related Topics
(learn more)
|
Tag this product(What's this?)Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items. |
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
Listmania!
So You'd Like to...
Look for Similar Items by Category
- Books > Business & Investing > Industries & Professions > MIS
- Books > Business & Investing > Management & Leadership > Industrial
- Books > Business & Investing > Management & Leadership > Management Science
- Books > New & Used Textbooks > Business & Finance
- Books > New & Used Textbooks > Medicine & Health Sciences > Medicine > Biotechnology
- Books > New & Used Textbooks > Science & Mathematics
- Books > Professional & Technical > Engineering
- Books > Science & Math > Biological Sciences > Biotechnology
